se of Itraconazole oral solution in Children with Fungal Infectio
Not Applicable
Completed
- Conditions
- Health Condition 1: B35- Dermatophytosis
- Registration Number
- CTRI/2019/05/019139
- Lead Sponsor
- Dr Ramesh Bhat M
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Patients age group of 1to12 years with clinical diagnosis of cutaneous dermatophytosis in glabrous skin (Tinea faciei, Tinea corporis and Tinea Cruris).
Both boys and girls will be included in the study.
Patients /parents/guardians who are consenting to participate in the study.
Patients with recurrent and extensive (10% body surface area) Tinea infection will be taken for the study.
Exclusion Criteria
•Patients with other pre-existing skin disorders.
•Patients/parents/guardians who are not willing to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety and Efficacy of Oral Itraconasole solution in Paediatric age groupTimepoint: Two weeks and Four weeks
- Secondary Outcome Measures
Name Time Method Tolerability and side effects of oral itraconazole solutionTimepoint: 2 weeks and 4 weeks